Publications by authors named "F Bourlon"
We report a 5-month-old infant who developed an unexpected acute ischaemia of the right lower limb following a surgical perimembranous interventricular communication closure. This rare case of ischaemia was due to an occlusive right common iliac artery dissection. It was early managed by angioplasty with two ABSORB® bioresorbable stents, resulted in complete revascularisation of the right leg.
View Article and Find Full Text PDFA case of a severe paravalvular mechanical mitral prosthesis leak (PVL) in a high-risk surgical patient, complicated with acute heart failure at presentation is described. Considering the high surgical risk and the specific echocardiographic features that would prevent the interventional cardiologist to have a direct access to the PVL with a traditional vascular plug or duct occluder, a percutaneous PVL closure with an Amplatzer-Amulet (Abbott, Abbott Park, Illinois, United States) LAA device (28 mm) was chosen for the contiguity of the PVL to the left atrial appendage (LAA). A new-onset hemolysis post-PVL closure and severe renal failure requiring hemodialysis occurred after the procedure, treated with surgical device removal and leak suture.
View Article and Find Full Text PDFArticle Synopsis
- A study analyzed data from French TAVR registries to compare long-term outcomes in patients using direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) after transcatheter aortic valve replacement (TAVR).
- The research found that patients on DOACs experienced lower mortality and major bleeding rates after three years compared to those on VKAs, although rates of ischemic events were similar between the two groups.
- The findings suggest that DOACs may be the preferred choice for oral anticoagulation therapy in TAVR patients, promoting better long-term safety and efficacy.
Transcatheter aortic valve implantation (TAVI) is an alternative to open surgical aortic valve replacement and the impact of diabetes on vascular outcomes is worth of investigation. The aim of our study was to determine if diabetic patients had distinct pre-operative characteristics compared to non-diabetics and to evaluate the impact of the disease on vascular outcomes. Four hundred consecutive patients who underwent TAVI with percutaneous transfemoral access were retrospectively included.
View Article and Find Full Text PDFBackground: The FRANCE-2 registry (French Aortic National Corevalve and Edwards) previously reported good early- and medium-term clinical and echocardiographic efficacy for transcatheter aortic valve replacement. We here report 5-year follow-up results from the registry.
Methods: The registry includes all consecutive patients undergoing transcatheter aortic valve replacement for severe aortic stenosis in France.